AlvaroMoreno-AspitiaMD

PubMed

• The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a...
  Diogo Martins-Branco, Marie Kassapian, Véronique Debien, Rafael Caparica, Daniel Eiger, Urania Dafni, Charitini Andriakopoulou, Sarra El-Abed, Susan L Ellard, Miguel I...> ;Breast Cancer Research and Treatment. 2024 Feb 1
• ASO Visual Abstract: Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node-Negative T1 Triple-Negative Breast Cancer.
  Kai Huang, James Jakub, Emmanuel Gabriel, Alvaro Moreno-Aspitia, Sarah McLaughlin> ;Annals of Surgical Oncology. 2023 Nov 1
• Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast Cancer.
  Kai Huang, James Jakub, Emmanuel Gabriel, Alvaro Moreno-Aspitia, Sarah McLaughlin> ;Annals of Surgical Oncology. 2023 Nov 1
• 1 citations
  Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model.
  Sibel Blau, Julio Antonio Peguero, Halle C F Moore, Ian Churchill Anderson, Minal A Barve, Mathew Amprayil Cherian, Ahmed Elkhanany, Ciara Catherine O'Sullivan, Alvaro...> ;JCO Clinical Cancer Informatics. 2023 Jun 1
• 5 citations
  A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.
  Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam Brufsky, E Claire Dees, Cesar A Santa-Maria, Roisin ...> ;NPJ Breast Cancer. 2022 Dec 30
• 1 citations
  Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer.
  Paolo Nuciforo, John Townend, Martine J Piccart, Shona Fielding, Panagiota Gkolfi, Sarra El-Abed, Evandro de Azambuja, Gustavo Werutsky, Judith Bliss, Volker Moebus, M...> ;European Journal of Cancer. 2023 Mar 1
• 2 citations
  Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
  Jennifer Berrian, Ying Liu, Nkiruka Ezenwajiaku, Alvaro Moreno-Aspitia, Sara J Holton, Adetunji T Toriola, Graham A Colditz, Ashley J Housten, Lannis Hall, Mark A Fial...> ;Cancer Medicine. 2023 Mar 1
• 1 citations
  Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTT...
  Guilherme Nader-Marta, Véronique Debien, Daniel Eiger, Zoi Tsourti, Rafael Caparica, Marie Kassapian, Sylvia Napoleone, Susanne Hultsch, Larissa Korde, Yingbo Wang, Sa...> ;British Journal of Cancer. 2022 Nov 1
• 6 citations
  PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer.
  Elisa Agostinetto, Lieveke Ameye, Samuel Martel, Philippe Aftimos, Noam Pondé, Christian Maurer, Sarra El-Abed, Yingbo Wang, Malou Vicente, Saranya Chumsri, Judith Bli...> ;NPJ Breast Cancer. 2022 Jul 20
• 4 citations
  Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials.
  Saranya Chumsri, Zhuo Li, Daniel J Serie, Nadine Norton, Afshin Mashadi-Hossein, Kathleen Tenner, Heather Ann Brauer, Sarah Warren, Patrick Danaher, Gerardo Colon-Oter...> ;NPJ Breast Cancer. 2022 May 24
• Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance).
  Kostandinos Sideras, David W Hillman, Karthik Giridhar, Brenda F Ginos, Richard C Tenglin, Heshan Liu, Beiyun Chen, Winston Tan, Gerald G Gross, Rex B Mowat, Amylou C ...> ;The Oncologist. 2022 Apr 21
• 10 citations
  Humoral Responses After SARS-CoV-2 mRNA Vaccination and Breakthrough Infection in Cancer Patients.
  Saranya Chumsri, Pooja P Advani, Tanmayi S Pai, Zhuo Li, Ashita Mummareddy, Marites Acampora, Gina A Reynolds, Natasha Wylie, Ashton W Boyle, Yanyan Lou, Kabir Mody, A...> ;Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 2022 Apr 1
• 2 citations
  Beta-2 adrenergic receptor gene (ADRB2) expression in HER2-positive early-stage breast cancer patients: a post-hoc analysis of the NCCTG-N9831 (Alliance) trial
  Rafael Caparica, Yaohua Ma, Claudia De Angelis, Francois Richard, Christine Desmedt, Ahmad Awada, Martine Piccart, Edith A. Perez, Alvaro Moreno-Aspitia, Sunil Badve, ...> ;Clinical Breast Cancer. 2021 Dec 2
• Correction to: Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub‑analysis of the ALTTO trial (BIG 2‑06; NCCTG (Alliance) N06...
  Noam Pondé, Dominique Agbor-Tarh, Lissandra Dal Lago, Larissa A Korde, Florentine Hilbers, Christian Jackisch, Olena Werner, Richard D Gelber, Aminah Jatoi, Amylou C D...> ;Breast Cancer Research and Treatment. 2022 Jan 1
• 113 citations
  Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
  Rosie Bradley, Jeremy P Braybrooke, Richard Gray, Robert Kerrin Hills, Z Liu, Richard Peto, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn W. Taylor, S...> ;The Lancet. Oncology. 2021 Aug 1
• 7 citations
  Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY).
  Judy C. Boughey, Vera J. Suman, Jia Yu, Katelyn Santo, Jason P. Sinnwell, Jodi M. Carter, Krishna R. Kalari, Xiaojia Tang, Sarah A. McLaughlin, Alvaro Moreno-Aspitia, ...> ;Clinical Cancer Research. 2021 Jun 2
• 1 citations
  Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a pros...
  Jia Yu, Bo Qin, Ann M. Moyer, Jason P. Sinnwell, Kevin J. Thompson, John A. Copland, Laura A. Marlow, James L. Miller, Ping Yin, Bowen Gao, Katherine Minter-Dykhouse, ...> ;Breast Cancer Research. 2021 Dec 1
• 10 citations
  Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D).
  Alvaro Moreno-Aspitia, Eileen Holmes, Christian Jackisch, Evandro de Azambuja, Frances M. Boyle, David W. Hillman, Larissa A. Korde, Debora Fumagalli, Miguel Izquierdo...> ;European Journal of Cancer. 2021 May 1
• 10 citations
  Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial.
  Samuel Martel, Matteo Lambertini, Dominique Agbor-Tarh, Noam Pondé, Andrea Gombos, Vicki Paterson, Florentine Hilbers, Larissa A. Korde, Anna Manukyants, Amylou C. Due...> ;Journal of the National Comprehensive Cancer Network. 2021 Jan 5
• 3 citations
  Tolerability and toxicity of trastuzumab or trastuzumab + lapatinib in older patients: a sub-analysis of the ALTTO trial (BIG 2-06; NCCTG (Alliance) N063D).
  Noam Pondé, Dominique Agbor-Tarh, Lissandra Dal Lago, Larissa A Korde, Florentine Hilbers, Christian Jackisch, Olena Werner, Richard D Gelber, Aminah Jatoi, Amylou C D...> ;Breast Cancer Research and Treatment. 2021 Jan 1
• 2 citations
  Case Report: Alpelisib-Induced Drug Reaction With Eosinophilia and Systemic Symptoms: A Rare Manifestation of a Common Side Effect
  Umair Majeed, Tudor Puiu, Jason C. Sluzevich, Gina Reynolds, Marites Acampora, Alvaro Moreno-Aspitia, Katherine J. Bodiford, Pooja Advani> ;Frontiers in Oncology. 2021 Jan 1
• 2 citations
  Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial.
  Matteo Lambertini, Dominique Agbor-Tarh, Otto Metzger-Filho, Noam Pondé, Francesca Poggio, Florentine Hilbers, Larissa A. Korde, Saranya Chumsri, Olena Werner, Lucia D...> ;ESMO Open. 2020 Nov 1
• 16 citations
  Intra-CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases.
  Kurt A. Jaeckle, Jesse G. Dixon, Stephen Keith Anderson, Alvaro Moreno-Aspitia, Gerardo Colon-Otero, Kathy Hebenstreit, Tejal Patel, Samarth L. Reddy, Edith A. Perez> ;Cancer Medicine. 2020 Sep 3
• N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-...
  Roberto A. Leon-Ferre, Edith A. Perez, David W. Hillman, Celyne Bueno, Alejandra T. Perez, Beiyun Chen, Robert B. Jenkins, Donald W. Northfelt, David B. Johnson, Rober...> ;Breast Cancer Research and Treatment. 2020 Aug 1
• Reply to T.J.A. Dekker
  Shanu Modi, Haeseong Park, Rashmi Krishna Murthy, Hiroji Iwata, Kenji Tamura, Junji Tsurutani, Alvaro Moreno-Aspitia, Toshihiko Doi, Yasuaki Sagara, Charles H. Redfern...> ;Journal of Clinical Oncology. 2020 Jul 13
• Join now to see all

Journal Articles

• Adjuvant Chemotherapy: To Use or Not To Use, The Anthracyclines  
  Crozier JA, Swaika A and Moreno-Aspitia A, World J Clin Oncol, 8/1/2014
• Current strategies for the prevention of breast cancer  
  Advani P and Moreno-Aspitia A, Breast Cancer: Targets and Therapy, 1/1/2014
• A church-based, Spanish language community education breast health program increases awareness and utilization of breast diagnostic services among Hispanic  
  Colon-Otero G, Albertie M, Rodriguez J, et al (Moreno-Aspitia A), Journal of Higher Education Outreach and Engagement, 1/1/2014
• A Phase II Study of AZD2171 (cediranib) in the Treatment of Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome  
  Mattison R, Jumonville A, Flynn PJ, Moreno-Aspitia A, et al, Leukemia and Lymphoma, 1/1/2014
• Overview of nanoparticle albumin-bound paclitaxel in metastatic breast cancer  
  Strauch DI, Moreno-Aspitia A, Breast Cancer Management, 5/1/2013
• The definition of IgM multiple myeloma  
  Schuster SR, Rajkumar SV, Dispenzieri A, Morice W, Aspitia AM, Ansell S, Kyle R, Mikhael J, Am J Hematol, 8/1/2011
• Triple-negative breast cancer and new treatment developments  
  Dyar S, Moreno-Aspitia A, Clinical Investigation, 8/1/2011
• A Practical Clinical Approach to Adjuvant Therapy in Breast Cancer - An Update  
  Hines SL, Tan WW, Moreno-Aspitia A, Roy V, Vallow LA, McLaughlin SA, Perez EA, US Oncol, 4/1/2009
• Author reply  
  Moreno-Aspitia A, Colon-Otero G, Cancer, 3/1/2007
• The adjuvant treatment of malignant melanomas with interferons  
  Moreno A, Maples WJ, Jacksonville Medicine, 10/1/1999
• A critical review of new treatments for the myelodysplastic syndromes  
  Colon-Otero G, Moreno A, Tefferi A, Cancer Research, Therapy & Control, 1/1/1999
• Join now to see all

Books/Book Chapters

• Diseases of the breast. 
  Chapter: Side effects of systemic therapy: neurocognitive, cardiac, and secondary malignancies. 
  Page 692 - 704Moreno Aspitia A, Perez EAEditors: Harris JR; et al.Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PAEdition 4th,2010

Abstracts/Posters

• Clonal selection of neoplastic cells in patients with resistance to neo-adjuvant chemotherapy. Poster presentation.
  Goetz MP, Barrett M, Kalari KR, et al (Moreno-Aspitia A), San Antonio Breast Cancer Symposium, 12/1/2014
• Evaluation of Taxane response in established xenografts derived from breast cancer patients.
  Yu J, Qin P, Yin P, et al (Moreno-Aspitia A), Individualizing Medicine: From Promise to Practice Conference, Rochester, MN, 10/6/2014
• Gene expression analysis in triple-negative breast cancers following neoadjuvant chemotherapy.
  Kalari KR, Suman VJ, Sinnwell JP, et al (Moreno-Aspitia A), Individualizing Medicine: From Promise to Practice Conference, Rochester, MN, 10/6/2014
• Identification of actionable germline mutations in women newly diagnosed with high risk breast cancer enrolled in the Breast cancer genome guided therapy study (BEAUTY).
  Ellingson MS, Schahl KA, Kalari KR, et al (Moreno-Aspitia A), Individualizing Medicine: From Promise to Practice Conference, Rochester, MN, 10/6/2014
• Analysis of sequencing data to identify potential drug targets for an individual newly diagnosed with basal breast cancer who failed to respond to current standard neo...
  Kalari KR, Tang X, Thompson KJ, et al (Moreno-Aspitia A), AACR Annual Meeting, San Diego, CA, 4/5/2014
• Feasibility of using percutaneous tumor biopsies from a prospective neoadjuvant breast cancer study to develop patient derived xenografts and assess in vivo Chemothera...
  Yu J, Yin P, Gao B, et al (Moreno-Aspitia A), AACR Annual Meeting, San Diego, CA, 4/5/2014
• Transcriptome-Wide Association of MKI67 Expression Pre- and Post- Neoadjuvant Chemotherapy.
  Moyer AM et al (Moreno-Aspitia A), United States & Canadian Academy of Pathology (USCAP) Annual Meeting, San Diego, CA, 3/1/2014
• Patient derived xenografts (PDX) from breast cancer patients before and after neoadjuvant chemotherapy: a prospective study.
  Boughey JC, Yu J, Ping Yin P, et al (Moreno-Aspitia A), Clin Oncol; ASCO, 1/1/2014
• Integration of next generation sequencing (NGS) and patient derived xenografts (PDX) to identify novel markers of paclitaxel (T) response in the Breast Cancer Genome G...
  Goetz MP, Boughey JC, Kalari KR, et al (Moreno-Aspitia A), Cancer Res, San Antonio Breast Cancer Symposium, 12/15/2013
• Safety and Quality of Care Improvement via Inpatient Chemotherapy Order Standardization.
  Maddox R, Fowler K, Vendrell N, et al (Moreno-Aspitia A), Mayo Clinic’s “Value Symposium”, Jacksonville, FL, 10/30/2013
• Estimation of tumor purity and clonal diversity from whole-exome DNA sequencing (WES) obtained from breast cancer core needle biopsies in women with newly diagnosed lo...
  Larson NB, PhD1, Sinnwell JP, Sicotte H, et al (Moreno-Aspitia A), Mayo Clinic’s “Individualizing Medicine to Practice” Conference, 9/30/2013
• Meta-analysis of deep sequencing data for an individual diagnosed with basal breast cancer.
  Kalari KR, Tang X, Thompson KJ, et al (Moreno-Aspitia A), Mayo Clinic’s “Individualizing Medicine to Practice” Conference, 9/30/2013
• Personalized single-patient pathway analysis of signatures associated with response to neoadjuvant chemotherapy for breast cancer.
  Sicotte H, Kalari KR, Tang X, et al (Moreno-Aspitia A), Mayo Clinic’s “Individualizing Medicine to Practice” Conference, 9/30/2013
• Crozier JA, Necela BM, Thompson EA, Geiger J, Moreno-Aspitia A, et al, ASCO, 1/1/2013
• N0937(Alliance): Final clinical results and correlative data from the phase II trial of cisplatin (C) and the novel agent brostallicin (B) in patients with metastatic ...
  Moreno-Aspitia A, Liu H, Hillman D, et al, ASCO, 1/1/2013
• Intra-csf topotecan (topo) treatment in patients with neoplastic meningitis (nm) associated with 'responsive' malignancies.
  Jaeckle KA, Anderson SK, Willson A, Moreno-Aspitia A, Colon-Otero G, Patel T, Perez E, Neuro-oncol, 10/1/2012
• CALGB 40502/NCCTG N063H: Randomized phase III trial of weekly paclitaxel (P) compared to weekly nanoparticle albumin bound nab-paclitaxel (NP) or ixabepilone (Ix) with...
  Rugo HS, Barry WT, Moreno-Aspitia A, Lyss AP, Cirrincione C, Mayer EL, Naughton M, Layman RM, Carey LA, Somer RA, Perez EA, Hudis C, Winer EP, J Clin Oncol, 6/1/2012
• Personalized Medicine in Breast Cancer
  Moreno-Aspitia A, Global Biomarkers Consortium Annual Conference, Orlando, FL, 3/1/2012
• Phase II study of AZD2171 for the treatment of patients with myelodysplastic syndromes [Abstract 6570].
  O'Mahar SE, Jumonville A, Flynn PJ, Moreno-Aspitia A, et al, J Clin Oncol, 1/1/2012
• Randomized phase II study of two doses of pixantrone in patients with metastatic breast cancer, N1031 Alliance.
  Sideras K, Moreno-Aspitia A, Tenglin RC, Liu H, Lingle WL, Reinholz MM, Halling KC, Chen B, Gross G, Mowat RB, Dakhil SR, Perez EA, J Clin Oncol, 1/1/2012
• Phase I study of panobinostat (LBH489) and letrozole in postmenopausal women with metastatic breast cancer.
  Tan W, Allred JB, Moreno-Aspitia A, Northfelt DW, Ingle JN, Perez EA, J Clin Oncol, ASCO Annual Meeting Proceedings, 1/1/2012
• Phase II Trial of Brostallicin and Cisplatin in Patients with Metastatic Triple Negative Breast Cancer.
  Moreno-Aspitia A, Rowland KM, Liu H, et al, SABCS, 1/1/2012
• A phase II trial of rituximab for peripheral neuropathy associated with monoclonal gammopathy of undetermined significance (MGUS).
  Smith BE, Suarez GA, Witzig TE, Stevens JC, Bosch EP, Ross MA, Rubin DI, Dyck PJB, Boylan KB, Gornet MK, Fonseca R, Moreno-Aspitia A, Hentz JG, J Peripher Nerv Syst, 9/1/2011
• Phase II study of AZD2171 for the treatment of patients with acute myelogenous leukemia.
  Juckett M, LaPlant B, Flynn PJ, Jumonville A, Moreno-Aspitia A, Erlichman C, J Clin Oncol, 5/1/2011
• Correlation between BMI and Clinical Outcome of Patients with Early Stage HER2+ Breast Cancer from the N9831 Clinical Trial.
  Crozier J, Moreno-Aspitia A, Ballman KV, et al, SABCS, 1/1/2011
• Join now to see all

Lectures

• Advances in Breast Cancer Treatment 
  Jacksonville, FL - 10/4/2014
• Early Stage Breast Cancer (Annual Talk) 
  Mayo Clinic, Jacksonville, FL - 1/1/2014
• Breast Cancer - Adjuvant therapy. 
  Mayo Clinic, Jacksonville, FL - 1/1/2014
• Introduction to Chemotherapy 
  Mayo Clinic, Jacksonville, FL - 1/1/2014
• Metastatic Breast Cancer 
  Mayo Clinic, Jacksonville, FL - 1/1/2014
• Florida Doctor 
  Jacksonville, FL - 10/1/2012
• Breast Cancer Adjuvant Therapy 2012 
  Asuncion, Paraguay - 4/1/2012
• Medical Oncology 2012 
  Asuncion, Paraguay - 4/1/2012
• Personalized Medicine in Breast Cancer 
  Orlando, FL - 3/1/2012
• Novel Approaches to Metastatic Breast Cancer: Integrating Options in an Evolving Setting 
  Knoxville, TN - 1/1/2012
• Management of Triple Negative Breast Cancer: Early and Metastatic 
  Ponte Vedra, FL - 11/20/2011
• What is New on the Management of triple Negative Breast Cancer 
  Amelia Island, FL - 8/1/2011
• Update on Breast Oncology 
  Amelia Island, FL - 6/1/2011
• Update on Metastatic HER2 Positive Breast Cancer 
  Tampa, FL - 4/1/2011
• NCCTG Breast Committee Study Portfolio 
  Rochester, MN - 10/1/2010
• Update in the Adjuvant Treatment of HER2 Negative Breast Cancer 
  Amelia Island, FL - 8/1/2010
• Monoclonal Gammopathy, What do I do with it? 
  Amelia Island, FL - 6/1/2010
• Chronic Lymphoid Leukemias and its Variants 
  Mayo Clinic, Jacksonville, FL - 1/1/2010
• What is New on the Treatment of Metastatic Breast Cancer? 
  Amelia Island, FL - 8/1/2009
• Caring for the Breast Cancer Patient 
  Boca Raton, FL - 8/1/2009
• Management of Adjuvant and Metastatic Breast Cancer 
  Mayo Clinic, Jacksonville, FL - 4/1/2009
• Metastatic Breast Cancer: State of the Art, Ongoing and New Trials 
  Boston, MA - 10/1/2008
• Roadmap to the Treatment of MDS Faculty 
  New York City, NY - 2/1/2008
• Best of the SABCS 2007 
  Titusville, FL - 1/1/2008
• CME Hematology Faculty Update Meeting 
  Dallas, TX - 1/1/2008
• Join now to see all

Other

• Breast Cancer Update. TV Presentations 
  Moreno-Aspitia A, CNN en Espanol
  10/1/2011
• Update on Antiangiogenic Therapy for Advanced Breast Cancer 
  Moreno-Aspitia A, Boston University School of Medicine and the Angiogenesis Foundation
  http://www.angio.org/cme/breast4.php
  1/1/2011